| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 07/08/2008 | CA2150262C Multivalent and multispecific binding proteins, their manufacture and use |
| 07/03/2008 | WO2008077194A1 Receptor agonists |
| 07/03/2008 | WO2008027162A3 129xe biosensors and their use |
| 07/03/2008 | US20080161236 Therapeutic nucleic acid-3'-conjugates |
| 07/03/2008 | US20080161229 Compounding ingredients for basic cosmetics and basic cosmetics |
| 07/03/2008 | US20080161227 Peptide IPP is generated in high yields from preferably a small molecular weight protein having a high amount of -I-P-P- compared to -V-P-P- in its amino acid sequence; preferably the GMP fraction of kappa-casein is used; process comprises a single enzyme incubation step |
| 07/03/2008 | US20080160574 Chimeric coiled coil molecules |
| 07/03/2008 | US20080160519 Using presence of allelic variation in apoptoic protease activating factor 1 (APAf1) gene as a diagnostic indicator of biopolar disorders |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/02/2008 | EP1937709A1 A marker for prolonged rupture of membranes |
| 07/02/2008 | CN101210043A Rice bran immune peptide and preparing method thereof |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 06/26/2008 | US20080153979 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153740 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | US20080152701 Methods and Compositions for the Treatment and Prevention of Staphylococcus Infections |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152588 Metal Chelators and Methods of Their Use |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1933863A2 Parathyroid hormone analogues and methods of use |
| 06/25/2008 | EP0922226B2 Process for determining the status of an organism by peptide measurement |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/19/2008 | US20080146778 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 06/19/2008 | US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders |
| 06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 06/19/2008 | US20080145378 Means and Methods for Breaking Noncovalent Binding Interactions Between Molecules |
| 06/19/2008 | US20080145353 Perhydrolase |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/17/2008 | US7388077 Polypeptides having antimicrobial activity and polynucleotides encoding the same |
| 06/17/2008 | US7388072 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 06/12/2008 | WO2008070047A2 Immunogens in cancer stem cells |
| 06/12/2008 | WO2008070021A2 Methods for determining effectiveness of waste water tank deodorizers and synthetic waste compositions for use in said methods |
| 06/12/2008 | WO2008048560A3 Toll-like receptor agonist regulation of vegf-induced tissue responses |
| 06/12/2008 | US20080139794 Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides |
| 06/12/2008 | US20080139792 High Protein Concentration Formulations Containing Mannitol |
| 06/12/2008 | US20080139787 Fluorine-labeled compounds |
| 06/12/2008 | US20080139670 Drug Delivery System |
| 06/12/2008 | US20080139471 Compositions and methods to prevent cancer with cupredoxins |
| 06/12/2008 | US20080138914 Zeolite labeled with dye, stop-cock moiety, and affinity binding agent; visualized using magnetic resonance imaging and computed tomography |
| 06/12/2008 | US20080138857 Using nutrient broth containing escherichia to translated preferential messenger RNA sequences |
| 06/12/2008 | US20080138365 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 06/12/2008 | US20080138356 Pili from Mycobacterium Tuberculosis |
| 06/12/2008 | US20080138354 Adeno-associated viral vector comprising nucleic acids coding modified nuclear localization signal sequences for use in vaccination against viral infection; genetic vaccines |
| 06/12/2008 | CA2643826A1 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/10/2008 | US7385028 Modified non-natural amino acid polypeptides typically include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group; therapeutic, diagnostic, and other biotechnology uses |
| 06/05/2008 | US20080132469 Sh2 domain binding inhibitors |
| 06/05/2008 | US20080132443 inhibiting smooth muscle cell proliferation and/or migration; smooth muscle relaxation; increasing the contractile rate in heart muscle; promoting wound healing; reducing scar formation; disrupting focal adhesions; regulating actin polymerization; host cell; biomedical device |
| 06/05/2008 | US20080132440 Vitamin D or vitamin C complex with polyglutamic acid; improved stability; food, beverage, cosmetic; esterification |
| 06/05/2008 | US20080131946 Expression vector comprising nucleotide sequences coding lyase for use in transformation and expression in escherichia; producing scent compounds in micoorganism for use in cosmetics and food products |
| 06/05/2008 | US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy |
| 06/05/2008 | US20080131310 Introducing to synthetic waste water media a hydrogen sulfide generating microorganism and a waste water tank deodorizer to be tested, and measuring the time or delay for the generation of hydrogen sulfide to occur; bacterium |
| 06/03/2008 | US7381705 Inhibitors of hepatitis C virus |
| 06/03/2008 | US7381702 Methods of treating diabetes mellitus |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 05/29/2008 | US20080124449 mung bean protein degradation product obtained by hydrolyzing a mung bean-derived protein with a protease contained in anti-hypertensive, anti-arteriosclerotic, and antiobesity agent; side-effects reduction |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | EP1196587B1 Antigenic meningococcal peptides |
| 05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | US20080118941 For imaging live cells and subcellular trafficking processes; electroporation |
| 05/22/2008 | US20080118502 Using metalloproteinase modulators as stimulatory tools in tissue regeneration; tissue engineering |
| 05/22/2008 | US20080118497 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH) |
| 05/22/2008 | CA2669524A1 Collagen peptide composition and food or beverage containing the same |
| 05/20/2008 | US7375179 PRO19680 polypeptides |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/14/2008 | EP1067950B1 Neo-tryptophan |
| 05/14/2008 | CN101177449A Furca polypeptide, drug composition and use thereof |
| 05/13/2008 | US7371821 Polypeptide of given sequence used as immunogen; cytokine adjuvant; |
| 05/13/2008 | US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders |
| 05/13/2008 | US7371728 Prostate peptide substrate: Gly-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Met-Lys(FITC)-Cys-NH2 where Hyp is hydroxyproline, Chg is cyclohexylglycine and FITC is Fluorescein isothiocyanate; near-infrared fluorescence probe |
| 05/13/2008 | US7371579 Nickel-based reagents for detecting DNA and DNA-protein contacts |
| 05/08/2008 | US20080108553 Rationally designed media for cell culture |
| 05/08/2008 | US20080108551 Treatment of wounds |
| 05/08/2008 | US20080107601 Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease |
| 05/08/2008 | US20080107600 Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
| 05/07/2008 | CN101172996A Connecting peptide and polypeptide amalgamation representation method for polypeptide amalgamation representation |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 05/06/2008 | US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| 05/06/2008 | US7368127 Contacting at least one surface of a biomedical device formed from a reactive mixture comprising at least one latent reactive component with a coating effective amount of at least one peptide containing coating |
| 05/01/2008 | US20080103090 Polynucleotide; hybridization; recombinant vectors, host cells; diagnosis, prognosis; anticarcinogenic and antiproliferative agents; drug screening; genetic engineering |
| 05/01/2008 | US20080103088 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders |
| 04/24/2008 | WO2007095021A3 Novel compounds |
| 04/24/2008 | US20080096246 Zein-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080096208 Biomarkers for assessing response to c-met treatment |
| 04/24/2008 | US20080093219 Rod sensors formed from tail fiber protein from T even bacteriophage; hydrodynamics |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/16/2008 | EP1912069A2 Method to screen ligands using eukaryotic cell display |
| 04/10/2008 | US20080085529 Fluorescence assay for kinase activity |
| 04/03/2008 | WO2008002153A3 Novel polypeptides |
| 04/03/2008 | US20080081355 Activatable recombinant neurotoxins |
| 04/03/2008 | CA2664558A1 Analogs of ghrelin substituted at the n-terminal |
| 04/02/2008 | EP1905828A2 Optical sorting method |